Cátia Teixeira

Post-doc Fellowship

Short CV

Researcher ID

ORCID

Cátia Teixeira was graduated in Chemistry in 2003, Department of Chemistry, Faculty of Sciences, University of Porto. Two years later she received M.Sc. degree (Organic Chemistry) in the same faculty. She then moved to France, where she obtained her Ph.D. in Computational Medicinal Chemistry in 2009, ITODYS research centre, University Paris 7 - Paris Diderot. In 2008, Cátia was awarded the L'Oréal France - Unesco 2008 prize for her doctoral research work.

Cátia is now at the Associated Laboratory CICECO of the University of Aveiro and the Centre for Chemical Research of the University of Porto as a Post-Doctoral research fellow. Her post-doctoral project is aimed at novel heteroaromatic-peptidomimetic hybrid constructs able to act as multi-target antimalarials with potent activity against intraerythrocytic Plasmodium falciparum parasites and reduced propensity to elicit resistance.

 

 

Projects

Publications

Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: in vitro evaluation, homology modeling and molecular docking studies

Perez, B; Antunes, S; Goncalves, LM; Domingos, A; Gomes, JRB; Gomes, P; Teixeira, C
2013, JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 27, 9, 823-835.

Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues

Perez, BC; Fernandes, I; Mateus, N; Teixeira, C; Gomes, P
2013, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 23, 24, 6769-6772.

Cinnamic Acid/Chloroquinoline Conjugates as Potent Agents against Chloroquine-Resistant Plasmodium falciparum

Perez, B; Teixeira, C; Gut, J; Rosenthal, PJ; Gomes, JRB; Gomes, P
2012, CHEMMEDCHEM, 7, 9, 1537-1540.

Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials

Perez, BC; Teixeira, C; Figueiras, M; Gut, J; Rosenthal, PJ; Gomes, JRB; Gomes, P
2012, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 54, 887-899.

PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity

Perez, B; Teixeira, C; Albuquerque, IS; Gut, J; Rosenthal, PJ; Prudencio, M; Gomes, P
2012, MEDCHEMCOMM, 3, 9, 1170-1172.

Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors

Teixeira, C; Gomes, JRB; Couesnon, T; Gomes, P
2011, JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 25, 8, 763-775.

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug

Teixeira, C; Gomes, JRB; Gomes, P; Maurel, F
2011, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 46, 4, 979-992.

Falcipains, Plasmodium falciparum Cysteine Proteases as Key Drug Targets Against Malaria

Teixeira, C; Gomes, JRB; Gomes, P
2011, CURRENT MEDICINAL CHEMISTRY, 18, 10, 1555-1572.

Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors

Teixeira, C; Serradji, N; Maurel, F; Barbault, F
2009, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 44, 9, 3524-3532.

Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives as Potent HIV Fusion Inhibitors Targeting gp41.

Liu, K; Lu, H; Hou, L; Qi, Z; Teixeira, C; Barbault, F; Fan, BT; Liu, SW; Jiang, SB; Xie, L
2008, JOURNAL OF MEDICINAL CHEMISTRY, 51, 24, 7843-7854.

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".